Diagnostic utility of the lymphoid screening tube supplemented with TRBC1 for the assessment of T‐cell clonality

Authors: Blomme, S., Nollet, F., Boeckx, N., Cauwelier, B., Snauwaert, S., Emmerechts, J.

Source: International journal of laboratory hematology. 45(4):496-505

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187495505.0x000001&indx=1&recIds=ETOCvdc_100187495505.0x000001

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Authors: Falchi, L., Clausen, M. R., Offner, F., Vos, S., Brody, J., Linton, K. M., Snauwaert, S., Cordoba, R., Wu, J., Bykhovski, I., Wang, L., Rana, A., Belada, D.

Source: Hematological oncology. 41:207-208

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185003130.0x000001&indx=1&recIds=ETOCvdc_100185003130.0x000001

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

Authors: Janssens, A, Snauwaert, S, Bron, D, Berneman, Z, Offner, F, Van Bogaert, C, De Beleyr, B, Smet, A, Nielsen, L, Wapenaar, R, André, M

Source: Hematological oncology. 39

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138589492.0x000001&indx=1&recIds=ETOCvdc_100138589492.0x000001

Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR)

Authors: Fornecker, L., Delwail, V., Thieblemont, C., Ghesquieres, H., Bouabdallah, K., Tilly, H., Le Calloch, R., Morschhauser, F., Costello, R., Slama, B., Gyan, E., Chauchet, A., Ngirabacu, M., Durot, E., Choquet, S., Capdupuy, C., Le Goff, M., Voillat, L., Snauwaert, S., Amorim, S.

Source: Hematological oncology. 41:437-437

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185005286.0x000001&indx=1&recIds=ETOCvdc_100185005286.0x000001

PB2118: PHASE 3 RANDOMIZED STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH R/R DLBCL (LOTIS-5)

Authors: Hamadani, M., Linhares, Y., Gandhi, M. D., Chung, M., Adamis, H., Ungar, D., Carlo-Stella, C., Kingsley, E., Depaus, J., Snauwaert, S., Kwiatek, M., López-Jiménez, J.

Source: HemaSphere. 6:1989-1990

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165731822.0x000001&indx=1&recIds=ETOCvdc_100165731822.0x000001

P1214: SUBCUTANEOUS EPCORITAMAB + R-CHOP FOR FIRST-LINE TREATMENT OF PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA: PHASE 1/2 UPDATE

Authors: Clausen, M. R., Offner, F., Belada, D., Brody, J., Linton, K. M., Karimi, Y., Cordoba, R., Snauwaert, S., Abbas, A., Wang, L., Wu, J., Elliott, B., Falchi, L.

Source: HemaSphere. 6:1100-1101

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165716164.0x000001&indx=1&recIds=ETOCvdc_100165716164.0x000001

Colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis patients

Authors: Claus, B. O., Snauwaert, S., Haerynck, F., Daele, S., Baets, F., Schelstraete, P.

Source: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. 37(4):555-558

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN372286660&indx=1&recIds=ETOCRN372286660

In vitro generation of mature, naive antigen-specific CD8+ T cells with a single T-cell receptor by agonist selection

Authors: Snauwaert, S., Verstichel, G., Bonte, S., Goetgeluk, G., Vanhee, S., Van Caeneghem, Y., De Mulder, K., Heirman, C., Stauss, H., Heemskerk, M. H.

Source: LEUKEMIA. 28(4):830-841

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN351024639&indx=1&recIds=ETOCRN351024639

Specific Notch receptor-ligand interactions control human TCR- alpha beta / gamma delta development by inducing differential Notch signal strength

Authors: Van de Walle, I., Waegemans, E., De Medts, J., De Smet, G., De Smedt, M., Snauwaert, S., Vandekerckhove, B., Kerre, T., Leclercq, G., Plum, J.

Source: JOURNAL OF EXPERIMENTAL MEDICINE. 210(4):683-698

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN330599519&indx=1&recIds=ETOCRN330599519

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Authors: Snauwaert, S., Vanhee, S., Goetgeluk, G., Verstichel, G., Van Caeneghem, Y., Velghe, I., Philippe, J., Berneman, Z.N., Plum, J., Taghon, T.

Source: HAEMATOLOGICA -PAVIA THEN ROMA-. 97(10):1539-1547

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN321439959&indx=1&recIds=ETOCRN321439959

Notch induces human T-cell receptor γδ+ thymocytes to differentiate along a parallel, highly proliferative and bipotent CD4 CD8 double-positive pathway

Authors: Van Coppernolle, S., Vanhee, S., Verstichel, G., Snauwaert, S., van der Spek, A., Velghe, I., Sinnesael, M., Heemskerk, M. H., Taghon, T., Leclercq, G.

Source: LEUKEMIA. 26(1):127-138

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN305100077&indx=1&recIds=ETOCRN305100077

In vitro generation of immune cells from pluripotent stem cells

Authors: Vandekerckhove, B., Vanhee, S., Van Coppernolle, S., Snauwaert, S., Velghe, I., Taghon, T., Leclercq, G., Kerre, T., Plum, J., Wakao, H.

Source: FRONTIERS IN BIOSCIENCE. 16(4):1488-1504

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN298302297&indx=1&recIds=ETOCRN298302297

HIGH TOTAL METABOLIC TUMOR VOLUME AT BASELINE ALLOWS TO DISCRIMINATE FOR SURVIVAL PATIENTS IN RESPONSE AFTER R‐CHOP: AN ANCILLARY ANALYSIS OF THE REMARC STUDY

Authors: Cottereau, A., Vercellino, L., Casasnovas, O., Tilly, H., Feugier, P., Fruchart, C., Roulin, L., Oberic, L., Pica, G., Ribrag, V., Abraham, J., Simon, M., Gonzalez, H., Bouabdallah, R., Fitoussi, O., Sebban, C., Lopez, A., Macro, M., Sahnes, L., Morschhauser, F., Trotman, J., Corront, B., Choufi, B., Snauwaert, S., Godmer, P., Copie‐Bergman, C., Briere, J., Salles, G., Gaulard, P., Meignan, M., Thieblemont, C.

Source: Hematological oncology. 37:49-50

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100084071321.0x000001&indx=1&recIds=ETOCvdc_100084071321.0x000001

Dyspneu bij een 89-jarige vrouw: transthoracale ultrasonografie bij de diagnostische uitwerking

Authors: Snauwaert, S., Van Der Kelen, V., Voet, D., Petrovic, M.

Source: TIJDSCHRIFT VOOR GENEESKUNDE. 65(2/3):92-94

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN244772637&indx=1&recIds=ETOCRN244772637

In vitro generation of mature, naive antigen-specific CD8⁺ T cells with a single T-cell receptor by agonist selection.

Authors: Snauwaert, S¹, Verstichel, G¹, Bonte, S¹, Goetgeluk, G¹, Vanhee, S¹, Van Caeneghem, Y¹, De Mulder, K¹, Heirman, C², Stauss, H³, Heemskerk, M H M⁴, Taghon, T¹, Leclercq, G¹, Plum, J¹, Langerak, A W⁵, Thielemans, K², Kerre, T¹, Vandekerckhove, B¹

Source: Leukemia (08876924). Apr2014, Vol. 28 Issue 4, p830-841. 12p. 8 Graphs.

Subject Terms: *T cells, *T-cell receptor genes, *CELL cycle, *FUNCTIONAL analysis, *PEPTIDES

79 Intravenous colistin and neurotoxicity: recommendations for optimal use in cystic fibrosis (CF) patients

Authors: Schelstraete, P., Claus, B., Snauwaert, S., Haerynck, F., Van Daele, S., De Baets, F.

Source: JOURNAL OF CYSTIC FIBROSIS. 13(SUPP/2):S66-S66

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN354215754&indx=1&recIds=ETOCRN354215754

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.